牛叉诊股

[{"date":"2026.01.23","stock":"1.83","trade":"0.94","ind":"0.33"},{"date":"2026.01.22","stock":"-1.07","trade":"0.49","ind":"0.14"},{"date":"2026.01.21","stock":"-0.27","trade":"0.31","ind":"0.08"},{"date":"2026.01.20","stock":"-0.20","trade":"0.50","ind":"-0.01"},{"date":"2026.01.19","stock":"0.27","trade":"0.52","ind":"0.29"},{"date":"2026.01.16","stock":"-0.27","trade":"-0.85","ind":"-0.26"},{"date":"2026.01.15","stock":"-0.07","trade":"-0.72","ind":"-0.33"},{"date":"2026.01.14","stock":"0.60","trade":"-0.40","ind":"-0.31"},{"date":"2026.01.13","stock":"-0.27","trade":"0.86","ind":"-0.64"},{"date":"2026.01.12","stock":"1.43","trade":"0.28","ind":"1.09"},{"date":"2026.01.09","stock":"0.48","trade":"0.77","ind":"0.92"},{"date":"2026.01.08","stock":"0.96","trade":"0.84","ind":"-0.07"},{"date":"2026.01.07","stock":"-0.27","trade":"-0.50","ind":"0.05"},{"date":"2026.01.06","stock":"0.41","trade":"0.58","ind":"1.50"},{"date":"2026.01.05","stock":"2.76","trade":"2.21","ind":"1.38"},{"date":"2025.12.31","stock":"-0.77","trade":"-0.42","ind":"0.09"},{"date":"2025.12.30","stock":"0.42","trade":"-0.80","ind":"-0.00"},{"date":"2025.12.29","stock":"-0.77","trade":"-1.56","ind":"0.04"},{"date":"2025.12.26","stock":"-0.76","trade":"-0.59","ind":"0.10"},{"date":"2025.12.25","stock":"0.56","trade":"0.49","ind":"0.47"},{"date":"2025.12.24","stock":"0.28","trade":"0.14","ind":"0.53"}]

康缘药业,上证指数,中药指数

压力支撑

该股压力位为14.79元，支撑位为14.67元。

[{"text":"\u538b\u529b\u4f4d","value":"14.79","date":1769011200,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"14.67","date":1769011200,"color":"0x0b52a1"}]

多空趋势

多头行情中，上涨趋势有所减缓，可适量做高抛低吸。

macd kdj boll asi bias rsi wr vr

资金面诊股

诊断结果：3.1资金面打败了22%的股票主力控盘前10的股票

资金面得分最高的股票

主力控盘

据统计，近10日内主力没有控盘。

没有控盘
轻度控盘
中度控盘
高度控盘

行业资金

中药行业，近5日资金总体呈流出状态，请投资者谨慎关注该行业的个股。

更新时间：01月23日 20:31

机构今日流向(万元)	-166.02	机构5日流向(万元)	-3753.53
机构10日流向(万元)	-12450.59	机构20日流向(万元)	-15871.91

机构持仓

2025-12-31 与 2025-06-30 相比，主力机构持仓量减少29710.16万股，其中基金净减仓1家，主力净减仓160家，请投资者中长期谨慎为宜。

截止2025-12-31，共5家主力机构（基金5家），持仓量总计57.91万股，占流通A股0.10%
其中，基金持仓与2025-06-30相比：
增仓：0家，增持 0万股
减仓：1家，减持 3.72万股
新出现在主力名单中：4家，持有50.44万股
从主力名单中消失：164家，原持有29756.88万股

消息面诊股

诊断结果：5.5消息面打败了62%的股票今日有利好新闻的公司

近期该股消息面总体多空平衡，没有较强的利好或利空趋势。

消息面得分最高的股票

消息列表

一般消息	重大事项	关联交易	2025-12-30
一般消息	高管变动	取消监事会	2025-12-29
一般消息	股东大会	临时股东大会	2025-12-12
一般消息	重大事项	关联交易	2025-12-12
一般消息	高管变动	工作调整	2025-12-09
一般消息	重大事项	公司股东股份解押	2025-09-27
一般消息	分红转增	不分配不转增	2025-08-28
一般消息	高管变动	因个人原因	2025-06-20
一般消息	高管变动	因中国科学院院士兼职管理	2025-04-24
一般消息	分红转增	不分配不转增	2025-04-03
一般消息	重大事项	关联交易	2025-04-03

一年消息统计

	所有消息	重大消息	非重大消息
利好	0条	0条	0条
利空	0条	0条	0条

行业面诊股

诊断结果：7.7行业面打败了88%的股票中药行业最新资金流向

近10日来该行业走势不明显，明显跑赢大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。

行业面得分最高的股票

行业走势

近10日来该行业走势不明显，明显跑赢大盘。

[{"date":"2026.01.23","price":"0.33","value":"0.94"},{"date":"2026.01.22","price":"0.14","value":"0.49"},{"date":"2026.01.21","price":"0.08","value":"0.31"},{"date":"2026.01.20","price":"-0.01","value":"0.50"},{"date":"2026.01.19","price":"0.29","value":"0.52"},{"date":"2026.01.16","price":"-0.26","value":"-0.85"},{"date":"2026.01.15","price":"-0.33","value":"-0.72"},{"date":"2026.01.14","price":"-0.31","value":"-0.40"},{"date":"2026.01.13","price":"-0.64","value":"0.86"},{"date":"2026.01.12","price":"1.09","value":"0.28"},{"date":"2026.01.09","price":"0.92","value":"0.77"},{"date":"2026.01.08","price":"-0.07","value":"0.84"},{"date":"2026.01.07","price":"0.05","value":"-0.50"},{"date":"2026.01.06","price":"1.50","value":"0.58"},{"date":"2026.01.05","price":"1.38","value":"2.21"},{"date":"2025.12.31","price":"0.09","value":"-0.42"},{"date":"2025.12.30","price":"-0.00","value":"-0.80"},{"date":"2025.12.29","price":"0.04","value":"-1.56"},{"date":"2025.12.26","price":"0.10","value":"-0.59"},{"date":"2025.12.25","price":"0.47","value":"0.49"},{"date":"2025.12.24","price":"0.53","value":"0.14"}]

上证指数,中药行业

行业排名

排名	股票名称	1月涨跌幅	5日涨跌幅	评分
1	万邦德	38.44%	-0.71%	5.9分
2	维康药业	28.16%	-2.16%	4.4分
3	沃华医药	22.37%	0.80%	6.6分
4	盘龙药业	16.73%	1.39%	6.1分
5	寿仙谷	14.30%	2.95%	6.0分
6	天目药业	13.98%	6.30%	6.6分
7	恩威医药	10.85%	1.28%	5.9分
8	众生药业	10.64%	-2.58%	5.5分
9	方盛制药	9.83%	6.80%	6.9分
10	粤万年青	9.60%	0.09%	4.8分
11	特一药业	8.02%	4.08%	6.6分
12	以岭药业	7.51%	6.04%	6.2分
13	康惠股份	6.55%	4.91%	6.2分
14	仁和药业	6.39%	1.15%	5.3分
15	古汉医药	6.11%	1.81%	5.9分
16	ST香雪	6.10%	9.67%	5.8分
17	新光药业	5.73%	3.18%	5.4分
18	益盛药业	5.53%	4.73%	5.3分
19	新天药业	5.47%	4.02%	5.6分
20	康缘药业	5.03%	0.54%	6.1分
21	精华制药	5.02%	0.52%	5.7分
22	上海凯宝	4.89%	1.58%	5.8分
23	吉林敖东	4.53%	2.14%	5.7分
24	陇神戎发	4.23%	3.69%	5.7分
25	金花股份	4.12%	5.06%	6.0分
26	信邦制药	3.94%	4.57%	6.1分
27	三力制药	3.89%	3.54%	6.2分
28	亚宝药业	3.77%	3.30%	6.5分
29	振东制药	3.51%	1.31%	5.0分
30	-	3.32%	0.81%	分
31	奇正藏药	2.90%	1.72%	5.5分
32	汉森制药	2.83%	2.37%	5.9分
33	红日药业	2.78%	2.49%	5.3分
34	千金药业	2.42%	2.42%	6.6分
35	东阿阿胶	2.36%	2.26%	5.4分
36	华森制药	2.34%	1.66%	5.3分
37	济川药业	2.31%	2.93%	6.5分
38	华神科技	2.27%	6.02%	5.7分
39	昆药集团	2.00%	-1.32%	5.2分
40	-	1.93%	0.42%	分
41	太极集团	1.92%	1.25%	5.4分
42	康恩贝	1.32%	2.22%	6.1分
43	益佰制药	0.72%	3.19%	5.4分
44	九芝堂	0.67%	2.15%	5.7分
45	康美药业	0.52%	1.04%	5.4分
46	桂林三金	0.41%	1.94%	6.0分
47	佐力药业	0.24%	0.06%	5.3分
48	太龙药业	0.15%	3.94%	6.4分
49	天士力	0.13%	1.33%	6.0分
50	羚锐制药	0.00%	0.38%	5.5分
51	佛慈制药	-0.55%	3.31%	5.6分
52	云南白药	-0.62%	-0.09%	5.1分
53	健民集团	-0.62%	1.18%	6.0分
54	嘉应制药	-0.82%	2.27%	5.3分
55	华润三九	-1.12%	-0.94%	4.9分
56	葵花药业	-1.47%	-0.47%	3.4分
57	达仁堂	-1.63%	0.86%	4.8分
58	马应龙	-1.95%	0.07%	4.7分
59	白云山	-1.97%	1.00%	5.6分
60	同仁堂	-4.31%	-2.19%	4.0分
61	片仔癀	-4.45%	-3.82%	3.9分
62	江中药业	-4.52%	3.90%	6.6分
63	中恒集团	-5.32%	2.30%	5.3分
64	珍宝岛	-12.17%	-6.63%	4.7分
65	ST百灵	-15.94%	-1.39%	4.9分
66	ST葫芦娃	-19.05%	3.48%	4.8分
67	*ST长药	-36.55%	70.37%	5.2分
68	步长制药	-	3.52%	6.4分
69	广誉远	-	0.39%	6.0分

<上一页 1 2 3 4 5...12 下一页>

行业评级

最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。

综合评级

研究机构	评级日期	最新评级	上次评级
中信证券	2012-09-10	增持	增持
招商证券	2012-09-08	增持	增持
航天证券	2012-09-06	增持	-
中银国际	2012-09-05	增持	-
齐鲁证券	2012-09-05	增持	-

基本面诊股

诊断结果：6.2基本面打败了64%的股票连续3年业绩增长30%的公司

该公司运营状况尚可，多数机构认为该股长期投资价值较高，投资者可加强关注。

个股深一度

潜在高分红能力：中（87.5分）

基本面得分最高的股票

[ 截止日期：2025-09-30 ]公司经营

盈利能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 37/109 ， 15/109。

[{"date":"2025-09-30","value":"4.33","vol":"4.74"},{"date":"2025-06-30","value":"3.10","vol":"3.98"},{"date":"2025-03-31","value":"1.83","vol":"2.21"},{"date":"2024-12-31","value":"8.07","vol":"4.80"},{"date":"2024-09-30","value":"6.91","vol":"2.91"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
净资产收益率(%)	4.33	3.10	1.83	8.07	6.91
行业(%)	4.74	3.98	2.21	4.80	2.91

该指标值越高，盈利能力越强，行业排名越靠前。

[{"date":"2025-09-30","value":"69.47","vol":"52.31"},{"date":"2025-06-30","value":"70.88","vol":"52.86"},{"date":"2025-03-31","value":"74.18","vol":"53.38"},{"date":"2024-12-31","value":"73.22","vol":"52.74"},{"date":"2024-09-30","value":"74.20","vol":"53.11"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
销售毛利率(%)	69.47	70.88	74.18	73.22	74.20
行业(%)	52.31	52.86	53.38	52.74	53.11

该指标值越高，盈利能力越强，行业排名越靠前。

成长能力：偏弱，与行业平均有较大差距，两项指标的行业排名分别为 57/109 ， 50/109。

[{"date":"2025-09-30","value":"-24.59","vol":"-7.31"},{"date":"2025-06-30","value":"-27.29","vol":"-7.31"},{"date":"2025-03-31","value":"-35.38","vol":"-7.18"},{"date":"2024-12-31","value":"-19.86","vol":"-7.35"},{"date":"2024-09-30","value":"-11.06","vol":"-5.11"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
营业收入同比增长率(%)	-24.59	-27.29	-35.38	-19.86	-11.06
行业(%)	-7.31	-7.31	-7.18	-7.35	-5.11

该指标值越高，成长能力越强，行业排名越靠前。

[{"date":"2025-09-30","value":"-35.63","vol":"-2.54"},{"date":"2025-06-30","value":"-40.12","vol":"2.98"},{"date":"2025-03-31","value":"-38.37","vol":"-37.19"},{"date":"2024-12-31","value":"-15.58","vol":"-146.29"},{"date":"2024-09-30","value":"2.18","vol":"61.78"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
净利润同比增长率(%)	-35.63	-40.12	-38.37	-15.58	2.18
行业(%)	-2.54	2.98	-37.19	-146.29	61.78

该指标值越高，成长能力越强，行业排名越靠前。

营运能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 34/109 ， 35/109。

[{"date":"2025-09-30","value":"0.34","vol":"0.35"},{"date":"2025-06-30","value":"0.24","vol":"0.24"},{"date":"2025-03-31","value":"0.13","vol":"0.12"},{"date":"2024-12-31","value":"0.56","vol":"0.50"},{"date":"2024-09-30","value":"0.44","vol":"0.37"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
总资产周转率(次)	0.34	0.24	0.13	0.56	0.44
行业(次)	0.35	0.24	0.12	0.50	0.37

该指标值越高，营运能力越强，行业排名越靠前。

[{"date":"2025-09-30","value":"1.45","vol":"1.73"},{"date":"2025-06-30","value":"0.96","vol":"1.18"},{"date":"2025-03-31","value":"0.43","vol":"0.61"},{"date":"2024-12-31","value":"2.34","vol":"2.42"},{"date":"2024-09-30","value":"1.79","vol":"1.81"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
存货增长率(次)	1.45	0.96	0.43	2.34	1.79
行业(次)	1.73	1.18	0.61	2.42	1.81

该指标值越高，营运能力越强，行业排名越靠前。

现金流能力：数据暂时不全，请后续关注

[{"date":"2025-09-30","value":"28.78","vol":"9.48"},{"date":"2025-06-30","value":"8.82","vol":"20.05"},{"date":"2025-03-31","value":"8.77","vol":"-0.23"},{"date":"2024-12-31","value":"12.05","vol":"15.64"},{"date":"2024-09-30","value":"25.51","vol":"5.86"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
现金流量净额/营业收入	28.78	8.82	8.77	12.05	25.51
行业	9.48	20.05	-0.23	15.64	5.86

该指标值越高，现金流能力越强，行业排名越靠前。

[{"date":"2025-09-30","value":"","vol":"0.00"},{"date":"2025-06-30","value":"2.10","vol":"1.02"},{"date":"2025-03-31","value":"","vol":"0.00"},{"date":"2024-12-31","value":"2.33","vol":"1.45"},{"date":"2024-09-30","value":"","vol":"0.00"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
资本支出／折旧和摊销	-	2.10	-	2.33	-
行业	0.00	1.02	0.00	1.45	0.00

该指标值越低，现金流能力越强，行业排名越靠前。

短期偿债能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 1/109 ， 33/109。

[{"date":"2025-09-30","value":"2.00","vol":"3.05"},{"date":"2025-06-30","value":"1.93","vol":"2.90"},{"date":"2025-03-31","value":"1.82","vol":"2.99"},{"date":"2024-12-31","value":"1.76","vol":"2.88"},{"date":"2024-09-30","value":"2.60","vol":"3.25"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
流动比率	2.00	1.93	1.82	1.76	2.60
行业	3.05	2.90	2.99	2.88	3.25

该指标值越接近2，短期偿债能力越强，行业排名越靠前。

[{"date":"2025-09-30","value":"1.69","vol":"2.21"},{"date":"2025-06-30","value":"1.62","vol":"2.13"},{"date":"2025-03-31","value":"1.50","vol":"2.22"},{"date":"2024-12-31","value":"1.44","vol":"2.11"},{"date":"2024-09-30","value":"2.18","vol":"2.43"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
速动比率	1.69	1.62	1.50	1.44	2.18
行业	2.21	2.13	2.22	2.11	2.43

该指标值越接近1，短期偿债能力越强，行业排名越靠前。

长期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 31/109 ， 33/109。

[{"date":"2025-09-30","value":"27.11","vol":"33.12"},{"date":"2025-06-30","value":"28.97","vol":"33.87"},{"date":"2025-03-31","value":"30.42","vol":"33.29"},{"date":"2024-12-31","value":"31.88","vol":"34.05"},{"date":"2024-09-30","value":"22.70","vol":"32.87"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
资产负债率(%)	27.11	28.97	30.42	31.88	22.70
行业(%)	33.12	33.87	33.29	34.05	32.87

该指标值越接近50%，长期偿债能力越强，行业排名越靠前。

[{"date":"2025-09-30","value":"0.39","vol":"0.75"},{"date":"2025-06-30","value":"0.43","vol":"0.74"},{"date":"2025-03-31","value":"0.46","vol":"0.72"},{"date":"2024-12-31","value":"0.49","vol":"0.75"},{"date":"2024-09-30","value":"0.30","vol":"3.20"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
产权比率 (%)	0.39	0.43	0.46	0.49	0.30
行业(%)	0.75	0.74	0.72	0.75	3.20

该指标值越高，长期偿债能力越强，行业排名越靠前。

机构评级

最近60个交易日，机构评级以买入为主，认为该股票非常值得关注。

研究机构	评级日期	最新评级	上次评级
华泰证券	2025-10-31	买入

机构预测

机构预测该股2025年每股收益与前一年相同，长期投资价值一般。

[{"date":"2021","yellowRectValue":"3.21","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"4.34","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"4.64","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"3.92","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"3.83","blueLineValue":"0.68","type":"YC"}]

[康缘药业]

技术面诊股
资金面诊股
消息面诊股
行业面诊股
基本面诊股

【数据基于历史，不代表未来趋势；诊股基于模型与测试，需要投资者根据不同行情合理运用、独立判断、控制风险】

证券咨询服务提供：浙江同花顺云软件有限公司 [编号：zx0050]